Table 1.
Etiological Causes | Background of HCC Development |
---|---|
Metabolic Syndrome | Chronic InflammationFat accumulation in Hepatocytes Insulin ResistanceDiabetes MellitusObesityHypertension Fat accumulation in Hepatocytes Insulin Resistance Diabetes Mellitus Obesity Hypertension |
NAFLD | TNF αIL6LeptinResistin IL6 Leptin Resistin |
HBV | DNA integrationGenomic InstabilityChronic InflammationTissue DamageEpigenetic AlterationRegeneration, Scarring and Stellate Cell ActivationFibrosis Genomic Instability Chronic Inflammation Tissue Damage Epigenetic Alteration Regeneration, Scarring and Stellate Cell Activation Fibrosis |
HCV | Chronic inflammationNecrosisTissue damageEpigenetic AlterationRegeneration, Scarring and Stellate Cell ActivationFibrosis [66] Necrosis Tissue damage Epigenetic Alteration Regeneration, Scarring and Stellate Cell Activation Fibrosis [66] |
Autoimmune disease | Epigenetic Variants Predisposition HLAD AllelesRegulatory mRNAs ExpressionsRisk Allele SH2B3CTLA4 VariantsFAS/FASL mutationsFOXp3 generationsAIRE mutationsGATA2 dysfunctionAltered immune mechanism Impaired CD4+ cellsCD8 + cytotoxic damageActivation of NK cellsB cell DifferentiationAutoantibodiesComplement activationSecreted cytokinesInterferon cell induced liver damageDefectous T regIL signaling in liver damage [67] Predisposition HLAD Alleles Regulatory mRNAs Expressions Risk Allele SH2B3 CTLA4 Variants FAS/FASL mutations FOXp3 generations AIRE mutations GATA2 dysfunction Altered immune mechanism Impaired CD4+ cells CD8 + cytotoxic damage Activation of NK cells B cell Differentiation Autoantibodies Complement activation Secreted cytokines Interferon cell induced liver damage Defectous T reg IL signaling in liver damage [67] |
Nutritional carcinogen | Aflatoxin B1Chronic injuryGenetic and epigenetic alteration [68] Chronic injury Genetic and epigenetic alteration [68] |
Alcoholic Liver Disease | NecrosisInflammationRegeneration, Scarring and StellateCell ActivationEpigenetic AlterationFibrosisGenetic Features TERT promoter MutationCTNNB1 MutationSignalling Pathways IL6-JAK STAT (more in steatotic Type) Wnt Beta catenin Signalling (more Cholestatic type)Chromosome Stability Chromosome 7 amplificationSteatotic type CRP+ Cholestatic TypeNuclear beta CateninCluster B/S3/iCluster 2G4 glass- InterferonPoly 7 subtypes WNT/Beta Catenine, CTTNNB1 Type -G5 G6 ClassIL6 -JAK STAT (more in Steatotic type) Wnt-Beta Catetine signaling (more in cholestatic type) Inflammation Regeneration, Scarring and Stellate Cell Activation Epigenetic Alteration Fibrosis Genetic Features TERT promoter Mutation CTNNB1 Mutation Signalling Pathways IL6-JAK STAT (more in steatotic Type) Wnt Beta catenin Signalling (more Cholestatic type) Chromosome Stability Chromosome 7 amplification Steatotic type CRP+ Cholestatic Type Nuclear beta Catenin Cluster B/S3/iCluster 2 G4 glass- Interferon Poly 7 subtypes WNT/Beta Catenine, CTTNNB1 Type -G5 G6 Class IL6 -JAK STAT (more in Steatotic type) Wnt-Beta Catetine signaling (more in cholestatic type) |
Age | Up to 7-fold increased risk of HCC > 55Genetic Predisposition [69] Genetic Predisposition [69] |
Overweight and Obesity | 8-fold increase risk of HCC |